His main research concerns Biochemistry, Ceramide, Enzyme, Sphingolipid and Fatty acid. His studies in Enzyme inhibitor, Cerebroside, Glycolipid, Sphingomyelin and Biosynthesis are all subfields of Biochemistry research. His work deals with themes such as Sphingosine, Stereochemistry, Cell growth and Cell biology, which intersect with Ceramide.
His Sphingosine study incorporates themes from Thin-layer chromatography, Chromatography and Pyridoxal phosphate, Cofactor. His Sphingolipid research is multidisciplinary, relying on both Hydrolase, Lactosylceramide and Lipid signaling. His study in Fatty acid is interdisciplinary in nature, drawing from both Glucocerebroside and Moiety.
Norman S. Radin spends much of his time researching Biochemistry, Ceramide, Enzyme, Cerebroside and Stereochemistry. Fatty acid, Biosynthesis, Glucocerebroside, Metabolism and Glycolipid are the subjects of his Biochemistry studies. In the field of Fatty acid, his study on Polyunsaturated fatty acid overlaps with subjects such as Coenzyme A.
Norman S. Radin has included themes like Sphingomyelin, Cell growth, Sphingosine and Sphingolipid, Cell biology in his Ceramide study. His Cerebroside research focuses on Chromatography and how it relates to Aqueous solution. Norman S. Radin combines subjects such as Ketone and Active site with his study of Stereochemistry.
Norman S. Radin mainly focuses on Ceramide, Biochemistry, Sphingolipid, Enzyme and Stereochemistry. His Ceramide research is multidisciplinary, incorporating elements of Sphingomyelin, Cell growth, Sphingosine, Cancer cell and Cell biology. His study in Enzyme inhibitor, Biosynthesis, Glycosphingolipid, Glycolipid and Metabolism falls under the purview of Biochemistry.
The Biosynthesis study combines topics in areas such as In vitro, Thymidine, DNA synthesis, Bovine serum albumin and Cerebroside. His Sphingolipid research incorporates elements of Lactosylceramide, Endocrinology, Kidney, Internal medicine and Lipid signaling. His Stereochemistry study integrates concerns from other disciplines, such as Reactive oxygen species and Allylic rearrangement.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lipid extraction of tissues with a low-toxicity solvent
Atsushi Hara;Norman S. Radin.
Analytical Biochemistry (1978)
Extraction of tissue lipids with a solvent of low toxicity.
Norman S. Radin.
Methods in Enzymology (1981)
Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase.
Jin-ichi Inokuchi;Norman S. Radin.
Journal of Lipid Research (1987)
Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acid
Pierre Morell;Norman S. Radin.
Biochemistry (1969)
Lactosylceramide galactosidase: comparison with other sphingolipid hydrolases in developing rat brain.
Norman S. Radin;Liselotte Hof;Roy M. Bradley;Roscoe O. Brady.
Brain Research (1969)
Cell Cycle Arrest Induced by an Inhibitor of Glucosylceramide Synthase CORRELATION WITH CYCLIN-DEPENDENT KINASES
C. S. Sheela Rani;Akira Abe;Yan Chang;Nitsa Rosenzweig.
Journal of Biological Chemistry (1995)
Specificity in ceramide biosynthesis from long chain bases and various fatty acyl coenzyme A's by brain microsomes.
Pierre Morell;Norman S. Radin.
Journal of Biological Chemistry (1970)
Improved inhibitors of glucosylceramide synthase.
Akira Abe;Jin-ichi Inokuchi;Masayuki Jimbo;Hiroshi Shimeno.
Journal of Biochemistry (1992)
The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver.
M. David Ullman;Norman S. Radin.
Journal of Biological Chemistry (1974)
Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.
A. Abe;N. S. Radin;J. A. Shayman;L. L. Wotring.
Journal of Lipid Research (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Michigan–Ann Arbor
University of Michigan–Ann Arbor
University of New Mexico
Cornell University
Pacific Northwest Diabetes Research Institute
Cedars-Sinai Medical Center
University of Michigan–Ann Arbor
West Los Angeles College
Johns Hopkins University
University of California, San Diego
George Mason University
Southeast University
Saarland University
University of Southern California
University of Duisburg-Essen
Harvard University
Tohoku University
Wageningen University & Research
University of Oxford
Johns Hopkins University
University of Birmingham
Yonsei University
Catholic University of America
Nova Southeastern University
Medical College of Wisconsin
University of Amsterdam